These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9681236)

  • 21. Use of recombinant human granulocyte-colony stimulating factor in colorectal surgery.
    Wiik HT; Syrjälä HP; Silvennoinen-Kassinen SH; Laurila JJ; Haukipuro KA
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):819-22. PubMed ID: 10614959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy.
    Trillet-Lenoir V; Green J; Manegold C; Von Pawel J; Gatzemeier U; Lebeau B; Depierre A; Johnson P; Decoster G; Tomita D
    Eur J Cancer; 1993; 29A(3):319-24. PubMed ID: 7691119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of IL-3, GM-CSF and G-CSF in an adult with congenital neutropenia.
    Miyachi H; Nakamura Y; Shimizu H; Watanabe K; Arimori S; Ando Y
    Int J Hematol; 1992 Oct; 56(2):113-8. PubMed ID: 1384774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of idiopathic neutropenia in the elderly with recombinant human granulocyte colony-stimulating factor.
    Sonoda Y; Yashige H; Fujii H; Maekawa T; Abe T
    Acta Haematol; 1991; 85(3):146-52. PubMed ID: 1710409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression.
    Beveridge RA; Miller JA; Kales AN; Binder RA; Robert NJ; Harvey JH; Windsor K; Gore I; Cantrell J; Thompson KA; Taylor WR; Barnes HM; Schiff SA; Shields JA; Cambareri RJ; Butler TP; Meister RJ; Feigert JM; Norgard MJ; Moraes MA; Helvie WW; Patton GA; Mundy LJ; Henry D; Sheridan MJ
    Cancer Invest; 1998; 16(6):366-73. PubMed ID: 9679526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.
    Morstyn G; Foote MA; Walker T; Molineux G
    Acta Haematol; 2001; 105(3):151-5. PubMed ID: 11463988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 30. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
    Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D
    Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.
    Frampton JE; Lee CR; Faulds D
    Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation.
    Uyl-de Groot CA; Richel DJ; Rutten FF
    Eur J Cancer; 1994; 30A(11):1631-5. PubMed ID: 7530471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
    J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF).
    Krishnan K; Ross CW; Bockenstedt PL; Adams PT
    Clin Lab Haematol; 1997 Jun; 19(2):105-9. PubMed ID: 9218149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).
    Scherrer R; Geissler K; Kyrle PA; Gisslinger H; Jäger U; Bettelheim P; Laczika K; Locker G; Scholten C; Sillaber C
    Ann Hematol; 1993 Jun; 66(6):283-9. PubMed ID: 7686404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of accelerated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-CSF (Filgrastim therapy in patients with AIDS.
    Pitrak DL; Sutton SH; Tsai HC; Mullane KM; Pau AK
    AIDS; 1999 Feb; 13(3):427-9. PubMed ID: 10199239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.